Gujarat Kidney & Super Speciality Limited IPO

Mainboard

Hospital

Listed On: Dec 30, 2025 at ₹ 120.0(NSE)

₹ 14592 /128 Shares

Check Allotment

22 Dec, 2025

Open Date

24 Dec, 2025

Close Date

26 Dec, 2025

Allotment Date

30 Dec, 2025

Listing Date

Price Summary

Last Closing

105.45 (-7.5%)

52 Week High

123.00

52 Week Low

98.36

Last Update

30-Jan-2026 3:30 PM

Expected Premium

+ ₹0

*Expected Premium provided in this app is derived from market rumors. It is not a guaranteed indicator of the actual listing price and should be interpreted with caution.

Gujarat Kidney & Super Speciality IPO Live Subscription Details

View Subscription Details

QIB 1.06x

Retail 19.04x

NIIs 5.73x

BHNI 5.25x

SHNI 6.68x

Retail 19.04x

Total 5.21x

Last updated: 24 Dec 2025, 05:57 PM

Gujarat Kidney & Super Speciality IPO Issue Details

Issue Price ₹108-114 per equity share
Face Value ₹2 Per Equity Share
Total Issue Size 2,20,00,000 shares(aggregating up to ₹250.8 crore)
Fresh Share 2,20,00,000 shares(aggregating up to ₹250.8 crore)
Listing at BSE, NSE
List Price 120.0(NSE)
Listing Date 2025-12-30
Lead Manager Nirbhay Capital Services Pvt.Ltd.
Registrar MUFG Intime India Pvt.Ltd.

Market Lot Size

Investors can bid for a minimum of 128 shares and in multiples thereof. The following table depicts the minimum and maximum investment by Retail Investors and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (min)	1	128	₹14,592
Retail(max)	13	1,664	₹1,89,696
SHNI(min)	14	1,792	₹2,04,288
SHNI(max)	68	8,704	₹9,92,256
BHNI(min)	69	8,832	₹10,06,848

Gujarat Kidney & Super Speciality IPO Reservation

Gujarat Kidney & Super Speciality IPO offers total 22000000 shares. Out of which 7726880 (35.12%) allocated to QIB, 3300000 (15%) allocated to NII,2200000 (10%) allocated to RII, NA (NA%) allocated to employees and 8773120 (39.88%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
Anchor Investor Shares Offered	8773120 (39.88%)
QIB Shares Offered	7726880 (35.12%)
NII (HNI) Shares Offered	3300000 (15%)
bNII > ₹10L	2200000 (NA%)
sNII < ₹10L	1100000 (NA%)
Retail Shares Offered	2200000 (10%)
Total Shares Offered	22000000 (100%)

Gujarat Kidney & Super Speciality IPO Documents

DRHP

RHP

ANCHOR

Gujarat Kidney & Super Speciality IPO Details

Gujarat Kidney & Super Speciality IPO is a book-built issue of ₹250.8 crores, The total issue size is ₹250.8 crores. The IPO of Gujarat Kidney & Super Speciality is priced at ₹108-114 per equity share, which has a face value of ₹2 Per Equity Share each, IPO bidding starts from Dec 22, 2025 and ends on Dec 24, 2025. The allotment for Gujarat Kidney & Super Speciality IPO will be finalized on Dec 26, 2025. Gujarat Kidney & Super Speciality IPO will be listed on BSE, NSE, with a tentative listing date fixed as Dec 30, 2025. The company shall list its equity shares on the BSE, NSE. MUFG Intime India Pvt.Ltd. is the registrar of the issue.

Retail investors can bid for a minimum of 128 shares, extendable to 14,592. S-HNIs will be able to bid for 1,792 shares at ₹2,04,288, while B-HNIs can also apply for a bid of 8,832 shares at ₹10,06,848. The book-running lead manager for the IPO is/are Nirbhay Capital Services Pvt.Ltd..

The total issue ₹250.8 crore, comprising a fresh issue of 2,20,00,000 shares ₹250.8 crore
The Gujarat Kidney & Super Speciality IPO sets its price band at 108-114 for each share. A single application for Gujarat Kidney & Super Speciality Limited IPO must contain at least 128 shares. Sentiment investors need to invest a minimum of 128 through their retail account. For investors to prevent oversubscription issues, they should submit bids at the cutoff price, which estimates about ₹14,592 In order to participate in the sNII, investors must purchase at least 14 lots of 1,792 shares for ₹2,04,288, while the bNII requires 69 lots of 8,832 shares for an investment of ₹10,06,848.

As on	QIB	NII bNII sNII	Retail	Total
Shares Offered / Reserved	77,26,880	33,00,000 22,00,000 11,00,000	22,00,000	1,32,26,880
Day 1 22-12-25 05:00 PM	0.34 x	1.97 x 2.48 x 0.96 x	4.87 x	1.50 x
Day 2 23-12-25 05:00 PM	0.34 x	2.95 x 3.18 x 2.48 x	10.51 x	2.68 x
Day 3 24-12-25 05:00 PM	1.06 x	5.73 x 5.25 x 6.68 x	19.04 x	5.21 x

Total No of Applications

2,62,553

Subscription on the basis of Applications

Retail:14.98x BHNI:1.04x SHNI:5.99x

Gujarat Kidney & Super Speciality Valuations

EPS Pre IPO ₹1.85/-

EPS Post IPO ₹2.74/-

P/E Pre IPO 61.62

P/E Post IPO 41.59

ROE 36.61%

ROCE 37.65%

Debt/Equity 0.15

RoNW 36.61%

PAT Margin 23.61%

Price to Book Value 22.62

Market Cap. 898.81 Cr.

Gujarat Kidney & Super Speciality Company Financials

In Crs.

In Cr.

	30-Jun-25	31-Mar-25	31-Mar-24	31-Mar-23
Assets	61.59	55.34	20.53	3.87
Revenue	15.27	40.40	5.48	0.00
Profit After Tax	5.40	9.50	1.71	-0.01
Net Worth	30.56	25.71	10.80	0.37
Reserves & Surplus	19.42	14.57	10.60	0.17
Total Borrowing	4.03	3.88	1.94	N/A

About Gujarat Kidney & Super Speciality Company

Incorporated in 2019, Gujarat Kidney and Super Speciality Limited (GKASSL) is a multispecialty health care service provider engaged in the provision of secondary and tertiary health care services in multiple locations across Gujarat, India.

At the close of business on March 20, 2025, it operates six multispeciality hospitals and three pharmacies, representing a total bed capacity of 400 beds with an approved capacity of 355 beds and an operational capacity of 250 beds.
The hospitals in the company include Gujarat Kidney and Super Speciality Hospital, Vadodara, Gujarat Multispeciality Hospital, Godhra, Raj Palmland Hospital Private Limited, Bharuch, M/s. Surya Hospital and ICU, Borsad, Gujarat Surgical Hospital, Vadodara, and Ashwini Medical Centre, Anand. It also holds a drugstore, Ashwini Medical Store, Anand.

Services:
Secondary Care Services: This refers to both general and surgical treatments.
Tertiary Care Services: Super speciality surgical procedures.

Gujarat Superspeciality Hospital provides medical care in the field of internal medicine, general surgery, minimally invasive procedures, orthopaedics and trauma treatment, joint replacement surgery, obstetrics and gynaecology, respiratory failure, non-interventional cardiology, diabetology, and anaesthesiology. At March 20, 2025, the company had 322 employees, which include 21 full-time Consultants and 32 visiting consultants. At September 30, 2024, the healthcare professionals of the company comprised 47 doctors and 138 nurses.

Gujarat Kidney & Super Speciality - Promoter(s)

Dr. Pragnesh Yashwantsinh Bharpoda

Dr. Bhartiben Pragnesh Bharpoda

Dr. Yashwantsingh Motisinh Bharpoda

Anitaben Yashwantsinh Bharpoda

Pre Issue Share Holding : 99.10%

Post Issue Share Holding : 71.45%

Gujarat Kidney & Super Speciality IPO - Issue Objectives

Proposed acquisition of Parekhs Hospital at Ahmedabad.

Part-payment of purchase consideration for the already acquired Ashwini Medical Centre

Funding of capital expenditure requirements of the Company towards setting up of a new hospital in Vadodara.

Buying robotics equipment for our hospital Gujarat Kidney & Super Speciality hospital in Vadodara location.

Full or part repayment and/or prepayment of certain outstanding secured borrowings availed by the Company

Funding inorganic growth through unidentified acquisitions and General Corporate Purposes.Dr. Pragnesh Yashwantsinh Bharpoda, Dr. Bhartiben Pragnesh Bharpoda, Dr. Yashwantsingh Motisinh Bharpoda and Anitaben Yashwantsinh Bharpoda

Gujarat Kidney & Super Speciality IPO - Anchor Investors

Gujarat Kidney and Super Speciality rakes in more than Rs 100 crore through anchor book ahead of the IPO.
Craft Emerging Market Fund, through its two sub funds viz. Citadel Capital Fund and Elite Capital Fund is the largest investor in the company's anchor book, subscribing 39.47 lakh shares at Rs 45 crore.
This comes after Khandelwal Finance and Venus Investments picked 13.16 lakh shares for Rs 15 crore, and 8.77 lakh shares for Rs 10 crore, respectively.
Other investors in the anchor book included Nexus Global Opportunities Fund, Arnesta Global Opportunities Fund, Zeta Global Funds, Religo Commodities Ventures Trust, Sunrise Investment Trust, and Innovative Vision Fund, which bought 4.38 lakh shares each for Rs 5 crore in Gujarat Kidney.

Gujarat Kidney & Super Speciality IPO - Peers Comparison

	P/B Ratio	P/E Ratio	RoNW	Revenue(in Cr.)
Gujarat Kidney	N/A	N/A	36.6%	N/A
Yatharth Hospital	9.3	55.8	8.1%	880
Gpt Healthcare	3.7	24.5	20.1%	407
Kmc Speciality	3.0	52.6	13.0%	231

Strength

Expertise in Kidney Sciences: The company has developed expertise in kidney sciences with sub-specialties in kidney diseases. This has been made possible by the multispecialty hospitals providing tertiary care.

Asset-Light Hospital Model of Operation: The hospitals are operated through leasing and majority-control companies so that assets do not serve as growth barriers by requiring significant investment in land and medical assets.

Ability to Attract and Retain Skilled Medical Talent: The low rate of staff turnover in doctors and nurses indicates that the company is able to attract and retain the best medical talent using the multidisciplinary and high-volume delivery system.

Weakness

Risks Relating to Proposed Acquisition of Parekhs Hospital: The proposed use of issue proceeds involves acquiring a 100% stake in Parekhs Hospital Private Limited. If any issue arises that prevents them from carrying out this proposed acquisition, this could pose a threat to their future business activities.

Funding Risk regarding Acquisition of Ashwini Medical Centre: The issue expenses are partly intended to be utilized for the partial payment of the already acquired Ashwini Medical Centre. This may create a hindrance in the funding aspect of the company.

Risk of Execution and Approvals in New Hospital Expansion: The proposed establishment of a woman’s healthcare hospital in the city of Vadodara faces risks in terms of delays in approvals, acquisition of capital equipment, rising costs due to inflation, and lease issues.

Contact Details

Gujarat Kidney & Super Speciality

Plot No. 1, City Sarve No. 1537/A, Jetalpur Road, Gokak Mill Compound, Alkapuri, Vadodara, Gujarat, India Vadodara, Gujarat, 390020

+91 265 298 48

info@gujaratsuperspecialityhospital.com

http://www.gujaratsuperspecialityhospital.com/

Registrar Contact Details

MUFG Intime India Private Limited (Link Intime)

+91-22-4918 6270

gujaratkidney.ipo@in.mpms.mufg.com

https://in.mpms.mufg.com/Initial_Offer/public-issues.html

Gujarat Kidney & Super Speciality IPO - FAQs

Ans. Gujarat Kidney & Super Speciality Limited IPO is a Mainboard IPO. The issue is priced at ₹108-114 per equity share. The minimum order quantity is 128 Shares. The IPO opens on Dec 22, 2025, and closes on Dec 24, 2025. MUFG Intime India Pvt.Ltd. is the registrar for the IPO. The shares are proposed to be listed on BSE, NSE.

Ans. The Gujarat Kidney & Super Speciality Limited IPO opens on Dec 22, 2025 and closes on Dec 24, 2025.

Ans. You can track the real-time subscription numbers using the links below:

Ans. The size of Gujarat Kidney & Super Speciality Limited IPO is 2,20,00,000 shares(aggregating up to ₹250.80 Cr).

Ans. The Gujarat Kidney & Super Speciality Limited IPO price band is set between ₹108-114 per equity share.

Ans. To apply for Gujarat Kidney & Super Speciality Limited IPO, follow the steps given below:

- Open the IPO Ji App or Website
- Find Gujarat Kidney & Super Speciality Limited IPO in the List of IPOs
- Press Apply Button
- Select Your Demat Account
- Select Your Shares Quantity and Submit
- Track Your IPO Status

Ans. The share allotment date of Gujarat Kidney & Super Speciality Limited IPO is Dec 26, 2025.

Ans. The Gujarat Kidney & Super Speciality Limited IPO will be listed on Dec 30, 2025.

Ans. Follow the steps to check the Gujarat Kidney & Super Speciality Limited IPO allotment status online.